Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB
Clinical trial NCT03469349 · COMPLETED
Trial details
- NCT number
- NCT03469349
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2019-05-28
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.